LLY

710.63

-0.99%↓

JNJ

152.58

+0.25%↑

ABBV

183.08

+0.8%↑

NVO

66.83

-1.85%↓

UNH

293.29

-2.75%↓

LLY

710.63

-0.99%↓

JNJ

152.58

+0.25%↑

ABBV

183.08

+0.8%↑

NVO

66.83

-1.85%↓

UNH

293.29

-2.75%↓

LLY

710.63

-0.99%↓

JNJ

152.58

+0.25%↑

ABBV

183.08

+0.8%↑

NVO

66.83

-1.85%↓

UNH

293.29

-2.75%↓

LLY

710.63

-0.99%↓

JNJ

152.58

+0.25%↑

ABBV

183.08

+0.8%↑

NVO

66.83

-1.85%↓

UNH

293.29

-2.75%↓

LLY

710.63

-0.99%↓

JNJ

152.58

+0.25%↑

ABBV

183.08

+0.8%↑

NVO

66.83

-1.85%↓

UNH

293.29

-2.75%↓

Search

Emergent BioSolutions Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

6.4 -0.78

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

6.18

Max

6.5

Pagrindiniai rodikliai

By Trading Economics

Pajamos

99M

68M

Pardavimai

33M

222M

Pelnas, tenkantis vienai akcijai

0.71

Pelno marža

30.603

Darbuotojai

900

EBITDA

37M

50M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+109.95% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

48M

365M

Ankstesnė atidarymo kaina

7.18

Ankstesnė uždarymo kaina

6.4

Naujienos nuotaikos

By Acuity

50%

50%

174 / 382 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Emergent BioSolutions Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-22 23:48; UTC

Karštos akcijos

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

2025-05-22 23:07; UTC

Svarbiausios naujienos

Fortescue Energy CEO to Resign in Executive Overhaul

2025-05-22 23:03; UTC

Pagrindinės rinkos jėgos

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

2025-05-22 23:59; UTC

Rinkos pokalbiai

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

2025-05-22 23:45; UTC

Rinkos pokalbiai

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

2025-05-22 23:45; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-05-22 23:23; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-05-22 23:23; UTC

Rinkos pokalbiai

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

2025-05-22 23:12; UTC

Svarbiausios naujienos

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

2025-05-22 21:54; UTC

Svarbiausios naujienos

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

2025-05-22 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-05-22 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-05-22 20:46; UTC

Įsigijimai, susijungimai, perėmimai

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

2025-05-22 20:39; UTC

Uždarbis

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

2025-05-22 20:36; UTC

Svarbiausios naujienos

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

2025-05-22 20:36; UTC

Svarbiausios naujienos
Uždarbis

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

2025-05-22 20:32; UTC

Svarbiausios naujienos
Uždarbis

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

2025-05-22 20:27; UTC

Svarbiausios naujienos

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

2025-05-22 20:20; UTC

Svarbiausios naujienos

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

2025-05-22 20:17; UTC

Svarbiausios naujienos

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

2025-05-22 20:16; UTC

Uždarbis

Intchains Group 1Q Rev $18.2M >ICG

2025-05-22 20:15; UTC

Svarbiausios naujienos

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

2025-05-22 20:08; UTC

Svarbiausios naujienos
Uždarbis

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

2025-05-22 20:05; UTC

Svarbiausios naujienos

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

2025-05-22 20:04; UTC

Uždarbis

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

2025-05-22 20:04; UTC

Uždarbis

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

2025-05-22 20:01; UTC

Uždarbis

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Net $68M >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q EPS 25c >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Adj EPS $2.23 >WDAY

Akcijų palyginimas

Kainos pokytis

Emergent BioSolutions Inc Prognozė

Kainos tikslas

By TipRanks

109.95% į viršų

12 mėnesių prognozė

Vidutinis 13.5 USD  109.95%

Aukščiausias 15 USD

Žemiausias 12 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Emergent BioSolutions Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

4.95 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

174 / 382 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Emergent BioSolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.